MedTrace Logo

Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications

NCT02699320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2016-03-04

No results posted yet for this study

Summary

There are no reports involved the intestinal microbiota from Chinese infants with short bowel syndrome (SBS) under different clinical status. Alterations in the microbiota are closely correlated with the bile acids and short chain fatty acids metabolism as well as the intestinal immunity. A relatively comprehensive profile composed of microbial structure, microbial metabolism products and immune biomarkers in SBS infants may facilitate a better therapy strategy to complications occurred in SBS children.

Conditions

  • Short Bowel Syndrome
  • Complications

Interventions

OTHER

Complications

Not involved

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Guangyu Chen, PhD · Shanghai Municipal Science and Technology Commission

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699320 on ClinicalTrials.gov